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Background: Acupuncture may effectively treat certain symptoms of Alzheimer’s disease (AD). Although several
studies have used functional brain imaging to investigate the mechanisms of acupuncture treatment on AD, these
mechanisms are still poorly understood. We therefore further explored the mechanism by which needling at ST36
may have a therapeutic effect in a rat AD model.
Methods: A total of 80 healthy Wistar rats were divided into healthy control (n = 15) and pre-model (n = 65) groups.
After inducing AD-like disease, a total of 45 AD model rats were randomly divided into three groups: the model
group (n = 15), the sham-point group (n = 15), and the ST36 group (n = 15). The above three groups underwent PET
scanning. PET images were processed with SPM2.
Results: The brain areas that were activated in the sham-point group relative to the model group were primarily centred
on the bilateral limbic system, the right frontal lobe, and the striatum, whereas the activated areas in the ST36 group were
primarily centred on the bilateral limbic system (pyriform cortex), the bilateral temporal lobe (olfactory cortex), the right
amygdala and the right hippocampus. Compared with the sham-point group, the ST36 group showed greater activation
in the bilateral amygdalae and the left temporal lobe.
Conclusion: We concluded that needling at a sham point or ST36 can increase blood perfusion and glycol metabolism
in certain brain areas, and thus may have a positive influence on the cognition of AD patients.
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Alzheimer’s disease (AD) is the most common form of
dementia in elderly individuals and is associated with
progressive memory loss and cognitive dysfunction. AD
is characterised by extensive cortical neuropathology,
including extracellular amyloid-containing neural pla-
ques, intracellular neurofibrillary tangles, and cell and
synapse loss in the cortical and subcortical regions of
the human brain [1-4]. Research is being performed
around the world to find a cure for this disease.
Acupuncture has therapeutic effects on Alzheimer’s
disease [5-10]. Many studies provide different explana-
tions as to how acupuncture may cure Alzheimer’s* Correspondence: nanfanglihuang@163.com; lai1023@163.com
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reproduction in any medium, provided the ordisease [11,12]. However, the mechanism is still un-
known. This study was based on functional brain im-
aging using positron emission tomography (PET) to
explore the mechanism of the therapeutic effect of acu-
puncture on AD. PET is a non-invasive imaging tech-
nique and can reveal the level of cellular metabolism.
This technique has been used to explore acupoint speci-
ficity and the relationship between needling specificity
and the response in cerebral regions [13]. Jia et al. [14],
Dong et al. [15], and Yin et al. [16,17] have all performed
similar studies based on PET to determine how needling
works. Their results showed that needling at different
acupoints can stimulate different brain regions. Our lit-
erature review revealed the following: (1) All of these
studies were performed on humans, and there have been
no PET studies to determine the effects of needling in
rats. (2) No functional brain imaging studies have been
performed on rat models of AD. This study is the firstThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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ST-36 (Zhusanli) as the needling point with the aim of
determining how needling at ST-36 affects the brain.
Methods
Design
A randomised, controlled animal experiment.
Time and setting
The study was performed at the Experimental Animals
Center of the China Academy of Chinese Medical Sci-
ences, the PET-CT centre of the Experimental Animals
Center of the General Hospital of PLA, and the Institute
of High Energy Physics of the Chinese Academy of
Sciences from January 2011 to October 2012.
Ethical statement
Animal care and sacrifice were conducted according to
methods approved by the Animal Care and Use Com-
mittee, Guangzhou University of Traditional Chinese
Medicine (TCM), Guangzhou, China. All experiments
were performed in accordance with the National Insti-
tute of Health Guide for the Care and Use of Labora-
tory Animals. This experiment was approved by the




Reagents and instruments were used in this research
were showed as Table 1.
Experimental animals
A total of 80 healthy 8-week-old Wistar rats (40 males
and 40 females) weighing 200–250 g were provided by
the animal centre of the China Academy of Chinese
Medical Sciences. The entire experimental procedureTable 1 Reagents and instruments used in this study
Reagents and instruments Type
D-Galactose (d-gal) -
Ibotenic acid (IBA) -
sodium pentobarbital -
sodium benzylpenicillin -
Normal sodium, NS -
stereotaxic apparatus WDT-2
18 F-FDG -
MicroPET imaging system nanoScan PET
ECAT EXACT HR + PET imaging system HR+
Animal breathing anaesthesia machine VME
isoflurane -
Rat Y-maze RD1102-YM-Rwas in accordance with the Guidelines for the Care and
Use of Laboratory Animals of the Ministry of Science
and Technology of the People’s Republic of China.
Methods
Primary experimental groups
The 80 rats were bought from the animal laboratory of
Guangzhou University of TCM, Guangzhou, and housed in
the Experimental Animals Center of the China Academy of
Chinese Medical Sciences. All rats were housed in separate
cages under conditions of controlled illumination (12:12 h
light/dark cycle), humidity, and temperature (18–22°C).
After 1 week of acclimatisation to the home cage, the rats
were randomly assigned to the healthy control (n = 15, 8
males and 7 females) or pre-model (n = 65, 32 males and
33 females) groups.
Generation of the animal model
The healthy control (HC) group was not subjected to
any treatment. The pre-model group received D-gal
(20 mg in 2 ml 0.9% saline, intraperitoneal injection
every day) for 6 weeks. After 6 weeks of intraperitoneal
D-gal injections, the pre-model rats were anesthetised
with pentobarbital (50 mg/kg). The head of each rat was
placed in a stereotaxic frame, and a needle with a syr-
inge (Hamilton) was placed in the right NBM, 0.9 mm
posterior and 2.8 mm lateral to the bregma and 6.9 mm
vertically from the skull surface. A stereotaxic injection
of 6 Ag of ibotenic acid in 0.3 Al of phosphate-buffered
saline (pH 7.4) was performed at a rate of 0.1 Al/min.
The syringe was left in place for more than 3 min at the
site of injection. The position of the lesion was con-
firmed using Nissl staining. Two weeks after the IBO in-
jection [18-20], all of the animals (including the HC and
pre-model animals) were subjected to the Y-maze test.
The rats in the pre-model group that met the standards
of the AD model were included in the next step. A totalSource
Shanghai No. 2 reagent company
Sigma Chemical Co. P.O.
Beijing Chemical Reagent Company
Harbin Group Pharmaceutical Factory
Guangxi Nanning Bai-hui Pharmaceutical Group Co., LTD
Xian Northwest Photoelectric Instrument Factory
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teria of the AD model (10 rats, 4 males and 6 females,
died during the D-gal treatment, and 5 rats, 3 males and
2 females, did not meet the criteria for the AD model)
and 15 healthy rats were included.
Secondary experimental groups
The 45 AD model rats were divided into three groups using
a random number table: the model group (n = 15, 7 males
and 8 females), the sham-point group (n = 15, 7 males and
8 females), and the ST36 group (n = 15, 8 males and 7 fe-
males). The three groups and the HC group underwent
PET scanning.
ST36 and sham point location
The ST36 point is located 5 mm directly below the ca-
pitulum fibulae, and the sham-point used was located
2 mm away from ST36 (Figure 1).
Needling method
Needling was performed on rats in the sham-point group
and the ST36 group the day after the AD model rats were
assigned to groups. Needling was performed at the Experi-
mental Animals Center of the China Academy of Chinese
Medical Sciences, from 08:00 to 12:00. Each rat was nee-
dled one time per day, and each single needling lasted for
almost 30 min. During needling, rats were fixed only by the
hand of the operator; furthermore, they were penetrated bi-
laterally. Needling was performed as follows: after the over-
lying skin was sterilised with an iodine tincture and alcohol,
sterile acupuncture needles (0.10 mm in diameter and
0.9 mm in length, manufactured by the Shuzhou Medical
Appliance Factory, Shuzhou, China) were inserted perpen-
dicularly into the selected points to a depth of 0.5–0.6 mm.
The needles were gently twisted, lifted and reinserted for
even reinforcing and reducing. The twisting was performed
within the range of 90–180° at a rate of 60–90 times/min.
The lifting and thrusting was performed within the range of
approximately 0.1–0.2 mm at a rate of 60–90 times/min.Figure 1 Location of ST36 and the sham point.[18 F] fludeoxyglucose (FDG)-PET imaging
All rats were sent to the PET-CT centre of the Experi-
mental Animals Center of the General Hospital of PLA
at 8:00 am after 24 h of fasting and were then subjected
to the following procedure: (1) The blood sugar level
was determined. (2) The rats were allowed to rest for
20 min in a dark room. (3) A tracer (18 F-FDG, synthe-
sised with Mini Tracer accelerator, 0.11 mci/kg dosage)
was injected via the tail vein. (4) The rats were allowed
to rest for 40 min. After tracer injection, the HC group
and the model group rats were allowed to move freely in
a small box for 30 min. Then, 30 min later, the HC
group and the model group rats received gas (isoflurane)
anaesthesia; the total time of gas anaesthesia was almost
10 min. The sham-point group rats and the ST36 group
rats underwent needling 2 min before the [18 F]FDG in-
jection. [18 F]FDG was injected via the tail vein with the
needle still in the acupoint (or sham-point). After finish-
ing the injection (which was performed over almost
1 min), the manipulation of the needle was continued as
before for an additional 7 min. The total needling time
was approximately 10 min. Then, the rats were allowed
to move freely in a small box, as for the model group.
Twenty minutes later, the rats were placed in a gas an-
aesthesia box for anaesthesia, and 10 min later, when the
rats were fully anaesthetised, they underwent PET scan-
ning. (5) The rats were subjected to a PET scan. PET
scans were performed on a Biograph Duo BGO scanner
(Siemens, Germany). The images covered the whole
brain and were parallel to the AC-PC line. Image acqui-
sition was started after a 40 min uptake period (bed: 1;
collection mode: 3D; slice thickness: 3 mm; slice interval:
1.5 mm; matrix size: 256 × 256; total counts: 3 × 109).
Upon the completion of data acquisition, the images
were reconstructed using ordered subset expectation
maximisation (OSEM) with 6 iterations and 16 subsets.
Statistical analysis
The preprocessing and data analysis were performed
using our self-developed toolbox for voxel-wise analysis
Table 2 Sham-point group compared with the model
group
Anatomical structure Volume T-Average x y z
R Limbic System: Septal Area 173 3.853346 41 16 62
R Frontal Lobe: Orbital Cortex 114 3.771888 44 36 78
L Corpus Callosum 137 3.714816 73 39 78
L Nucleus Accumbens 699 4.278525 71 26 73
L Limbic System: Septal Area 140 3.916688 61 26 72
L Striatum 1395 3.990151 82 32 71
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ment of Cognitive Neurology, London, UK), which com-
prised a FDG-PET rat brain template and atlas in
Paxinos & Watson space [21]. The images of all rats in
the model group, the sham-point group, the ST36 group
and the healthy controls were preprocessed using the
following main steps. (1) Segmentation. All the FDG-
PET functional images were registered to the average rat
brain with extracranial tissues using intensity-based
twelve-parameter affine transformation. The intracranial
mask image was employed to automatically crop brain
tissues from non-brain tissues in all images. (2) Normal-
isation. Each intracranial individual image was spatially
normalised with the intracranial FDG-PET rat brain
template in SPM8. (3) Smoothing. The spatially normal-
ised functional images were smoothed by a Gaussian
kernel of 2*2*4 (after zooming) full width at half-
maximum (FWHM). Preprocessed images were analysed
within SPM8 based on the framework of the general
linear model. To identify the difference of FDG signals
between the rats with AD and the healthy controls, two-Figure 2 Cerebral areas activated in the sham-point group vs. the mosample t-test was performed using SPM8. Proportional
scaling was applied to account for global confounds.
Brain regions with significant FDG changes in rats with
AD were yielded based on a voxel-level height threshold
of p < 0.001 (uncorrected) and a cluster-extent threshold
of 50 voxels.
Results
Compared with the model group, the sham-point group
exhibited a higher level of glycol metabolism in the right
nucleus accumbens, the septal area of the right limbic
system, the orbital cortex of the right frontal lobe, the
left corpus callosum, the left nucleus accumbens, and
the left striatum (Table 2, Figure 2). Compared with the
model group, the ST36 group exhibited a higher level of
glycol metabolism in the pyriform cortex of the right
limbic system, the olfactory cortex of the right temporal
lobe, the right amygdaloid body, the right hippocampus,
the pyriform cortex of the left limbic system, and the
olfactory cortex of the left temporal lobe (Table 3,
Figure 3). Compared with the sham-point group, the
ST36 group showed a higher level of glycol metabolism
in the right amygdaloid body, the olfactory cortex of the
left temporal lobe, and the left amygdaloid body (Table 4,
Figure 4).
Discussion
It is true that studies on acupoints should be performed
in humans, but we believe that studies conducted with
animals also have irreplaceable significance. To date,
several studies of acupuncture using functional brain im-
aging have been performed. However, all we know fromdel group.
Table 3 ST36 group compared with the model group
Anatomical structure Volume T-Average x y z
R Limbic System: Piriform Cortex 115 3.799693 14 26 46
R Temporal Lobe: Olfactory Cortex 172 4.328225 14 24 41
R Amygdaloid Body 364 3.790134 16 28 50
R Hippocampus 119 4.208104 16 26 45
L Limbic System: Piriform Cortex 120 3.587087 107 25 49
L Temporal Lobe: Olfactory Cortex 115 3.606412 107 27 52
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stimulate certain brain regions. Additionally, how these
activated brain regions affect the target organs and cure
diseases remains unknown. Many researchers have
thought about this gap in knowledge and have appealed
to others to perform studies in this field [22,23]. How-
ever, these studies may have negative consequences on
human subjects, and may require the analysis of brain
tissue or another organ that cannot obtained from live
humans. In contrast, it is easy to take these tissues from
rats. Therefore, it may be best to perform preliminary
studies in rats.
ST36 is the primary point of the four main acupoints
used in traditional medical practice that has distinctive
accommodation and therapeutic effects. This point is as-
sociated with more than ten common diseases, including
digestive, respiratory, circulatory, urinary and nervous
disorders. ST36 has been used for a long time in TCM
as the main point to treat AD. In addition, many recent
studies have demonstrated that ST36 plays an important
role in the treatment of AD [24,25]. Based on these fac-
tors, we chose ST36 as the research point.Figure 3 Cerebral areas activated in the ST36 group vs. the model grThe results of this study can be grouped into three
parts: (1) the brain regions with higher glycol metabol-
ism in the sham-point group relative to the model
group, (2) the brain regions with higher glycol metabol-
ism in the ST36 group relative to the model group, and
(3) the brain regions with higher glycol metabolism in
the ST36 group relative to the sham-point group.
Many functional brain-imaging studies have investigated
the effect of needling at ST36. Yin l et al. used PET to per-
form functional brain imaging while needling the ST36
points of six healthy volunteers, and they found that need-
ling at ST36 can increase glycol metabolism in the hypo-
thalamus, the head of the caudate nucleus, the temporal
lobe, the left cerebellum, the postcentral gyrus, and the
brain stem [17]. Wu Zhiyuan et al. used the BOLD se-
quence to observe the changes in the brain when perform-
ing acupuncture at the right ST36 of 12 healthy volunteers.
The data were analysed and compared using SPM2, and
this analysis revealed that there were increases in brain ac-
tivity in the left parahippocampal gyrus, the left middle
temporal gyrus, the left superior temporal gyrus, the right
superior temporal gyrus and the right supramarginal gyrus
when acupuncturing ST36 [26]. A study by Zhou investi-
gating the effect of needling at ST36 in AD showed very
similar result to our study. The differences between the two
studies were as follows: (1) Zhou used fMRI, but we used
PET; and (2) Zhou studied humans, but we studied rats.
Zhou found that the activated regions were primarily the
inferior frontal gyrus, the middle frontal gyrus, the superior
frontal gyrus, the transverse temporal gyrus, the left cere-
brum, the left superior frontal gyrus, the middle frontal
gyrus, the precentral gyrus, the hippocampal gyrus, theoup.
Table 4 ST36 group compared with the sham-point group
Anatomical structure Volume T-Average x y z
R Amygdaloid Body 170 4.421505 19 22 50
L Temporal Lobe: Olfactory Cortex 117 4.256156 107 27 54
L Amygdaloid Body 128 4.125938 96 19 56
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lobule of the right cerebrum. Zhou concluded that exciting
ST36 could improve the cognitive ability of AD patients
and that the mechanism may involve the activation of the
cognition-related regions of the frontal and temporal lobes
and the marginal system, as well as the cognition-related
region of the cerebellum [27]. Other studies have shown a
higher level of glycol metabolism in the No. 1 and 2
somesthetic areas, the No. 1 and 2 body movement areas,
the premotor area, the submotor area, the inferior parietal
lobe, the insula lobe, the cingulate gyrus, the prefrontal
lobe, the temporal lobe, the hippocampus, the head of the
caudate nucleus, the lenticular nucleus, the putamen,
the nucleus accumbens, the thalamus, the hypothalamus,
the paraventricular nucleus, the pons Varolii and the cere-
bellum [28-31]. Our results were quite different from most
past results but were similar to Zhou’s results, which may
be because Zhou’s study and our study included needling at
ST36 in AD instead of healthy controls.
Senile plaques, neurofibrillary tangles and neuron loss are
the three main neuropathologic changes in AD patients.
The senile plaques and neurofibrillary tangles first occur in
the medial temporal lobe (MTL), which includes the ento-
rhinal cortex, the hippocampus, the parahippocampal gyrusFigure 4 Cerebral areas activated by needling ST36 vs. the sham poinand the amygdala. When AD progress, these three main
features can spread to the neopallium, including the frontal
lobe and the parietal lobe, and can eventually reach the sen-
sory cortex [32]. In recent years, researchers have carried
out many studies on the central pathological mechanism of
AD. It has been generally acknowledged that in every patho-
logic stage of AD, the damaged spreads to different brain
regions. These damaged brain regions have lower blood
perfusion than is normal for elderly individuals. A previous
study provided evidence that the deficient blood perfusion
in damaged brain regions may be one of the main causes of
the progressive cognitive deficit in AD patients [33].
Our results showed that the brain areas activated in the
sham-point group relative to the model group were mainly
centred on the bilateral limbic system, the right frontal lobe,
and the striatum, whereas the activated areas in the ST36
group were mainly centred on the bilateral limbic system
(pyriform cortex), the bilateral temporal lobe (olfactory cor-
tex), the right amygdala and the right hippocampus. Com-
pared with the sham-point group, the ST36 group showed
activated brain regions in the bilateral amygdalae and the
left temporal lobe.
The limbic system contains structures that are involved
in emotion, memory and sensation. It is generally acknowl-
edged that the limbic lobe of the limbic system is primarily
located in the left hemisphere cortex. Our results revealed
an apparent activation of the limbic system when needling
the sham-point and ST36. Therefore, needling at these two
points may improve memory and cognitive function, but
these results may also be due to the rats’ sensations, such as
pain and fear.t.
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was based on the intraperitoneal injection of D-gal com-
bined with the injection of IBO into the basal nuclei.
This type of AD model rat mimics certain symptoms of
AD but does not completely recapitulate human AD.
We based our AD model on several previous studies
[18-20]. (2) We tested the development of AD in rats
using only a Y-maze test, and analysing some a biochem-
ical indicator may be better.
Conclusions
According to this study, We concluded that needling at
a sham point or ST36 can increase blood perfusion and
glycol metabolism in certain brain areas, and thus may
have a positive influence on the cognition of AD pa-
tients. And this may also give some helps to the clinical
doctors.
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